Investıgatıon of Temporomandıbular Dysfunctıon in Patıents Wıth Breast Cancer-Related Lymphedema

arife akbulut

Status

Completed

Conditions

Breast Cancer

Lymphedema

Treatments

Other: only assesment

Study type

Observational

Funder types

Other

Identifiers

NCT06669910

AYBU-AKBULUT-001

Details and patient eligibility

About

This study is the first study to examine temporomandibular joint dysfunction (TMD) in patients with breast cancer. The aim of the study was to investigate the relationship between lymphedema (LÖ) and TMD in patients with breast cancer. Socio-demographic characteristics of 38 individuals included in the study were recorded. Patients were divided into stage 0, 1 and 2 groups according to their LÖ stage and mild, moderate and advanced groups according to their TMD levels. In the evaluation of severity of lymphedema, Symptoms and Signs of TMD, pain threshold and tolerance assessment and normal range of motion, anxiety and depression, posture analysis environmental measurement, Craniomandibular Dysfunction Index for Clinical, Visual Analogue Scale (VAS) and algometer , goniometer and inclinometer, Turkish version of the Hospital Anxiety and Depression Scale (HAD) ,photogrammetric assessment method and inclinometer were used

Enrollment

38 patients

Sex

Female

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Female patients aged 18-75 years who were treated for unilateral breast cancer and developed breast cancer-related LE were included in the study

Exclusion criteria

Patients with general joint diseases affecting the head and neck region that may cause TMD (e.g. rheumatoid arthritis),
jaw fracture,
trauma or orthognathic surgery history,
cervical disc herniation,
congenital disease,
facial paralysis,
patients who have been treated for TMD for the last 3 months and patients who use antidepressant drugs were excluded.